Conductive Keratoplasty for the Treatment of Presbyopic Emmetropes and Hyperopes to Improve Near Vision FDA Clinical Trial Protocol RCS-0110PRS 24 Month.

Slides:



Advertisements
Similar presentations
Long-term Outcomes of Photorefractive Keratectomy for Anisometropic Amblyopia in Children Evelyn A. Paysse, MD, David K. Coats, MD, Mohamed A. W. Hussein,
Advertisements

Fernando Llovet, MD, PhD. Contributing Authors: Margarita Cabanás, MD; Jaime Beltrán, MD; Julio Ortega-Usobiaga, MD; Clara Martín- Reyes, MD; Victoria.
Results of the Prospective, Randomized, Multicenter FDA Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Versus Circumferential.
What Every Patient Should Know About Advanced CustomVue™
RESULTS OF MULTIFOCAL TREATMENT FOR PRESBYOPIA WITH VISX STAR S4 IR EXCIMER LASER AUTHOR: L. FELIPE VEJARANO, MD. CO – AUTHOR: IYALI.
Conductive Keratoplasty for the Correction of Low to Moderate Hyperopia: U.S. Clinical Trial 12-Month Results.
CBER Isolagen Therapy (IT) BLA FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.
Intracorneal Inlays for Presbyopia Moderator Ioannis Pallikaris Instructors Stephen Slade John Vukich Dimitrios Bouzoukis Insructional Course 59 19/9/2011.
Monovision for Presbyopia Insert name/ Practice name/ Logo here if desired.
IN THE NAME OF GOD.  Dr. Memarzadeh Ophthalmologist 1389.
Diffractive Multifocal IOL Prof. Dr. Daniel H. Scorsetti
Toric Artiflex J.L.GüellI.M.O. Instituto de Microcirugía Ocular de Barcelona Universidad Autónoma de Barcelona Universidad de Lugano ESCRS Vienna 2011.
Tarek Abdel-Wahab, MD Clear Vision Center Cairo,Egypt Clinical Consultant of Schwind and technolase.
Comparison of Early Outcomes of Topo-Guided PRK With Two Refractive Lasers WCC 2015 San Diego, California Simon P. Holland MB. FRCSC,FRCS,MRCP 1, 2, A,
Anupama Kotha 1, Simar J. Singh 1, William B. Trattler 1,2, Carlos Buznego 1,2 The authors have no financial interest in the subject matter of this poster.
Unilateral Implantation of Presbyopic Correcting IOLs – A Comparison of ReZoom, ReSTOR, Crystalens 5.0, and Crystalens HD Frank A. Bucci, Jr, MD Bucci.
GT BOGOTA LASER REFRACTIVE INSTITUTE BOGOTA COLOMBIA SOUTHAMERICA GUSTAVO E. TAMAYO MD BASIC PRINCIPLES OF PRESBYOPIA.
Presbyopia Walter Huang, OD Yuanpei University Department of Optometry.
Laser Vision Correction for Myopia, Myopic Astigmatism, Hyperopia and Hyperopic Astigmatism with CustomVis Solid State Laser (213nm) THE ROYAL AUSTRALIAN.
InFUSE ™ Bone Graft / LT-CAGE ™ Lumbar Tapered Fusion Device IDE Clinical Results G Hallett H. Mathews, M.D. Richmond, Virginia.
Topography-Guided Photorefractive Keratectomy for Irregular Astigmatism following Penetrating Keratoplasty Johnson Tan, MBBS MRCSEd (Ophth) FRCSEd (Ophth)
PMA P010018/SUPPLEMENT 5 FDA PRESENTATION. Indication for Use Temporary induction of myopia (-1D to -2D) to improve near vision in the non- dominant eye.
Physician Certification for CustomVue ™ Presbyopic Ablations.
Stefan Franzén Introduction to clinical trials.
Dr Umang Mathur, Dr Archana Gupta, Dr Suma Ganesh
Bret Fisher, MD The Eye Center of North Florida Panama City, FL
Autologous serum eye drops in severe post-LASIK dry eye.
Mike P. Holzer, MD Annett Mannsfeld, MSc Angela Ehmer, MSc Gerd U. Auffarth, MD International Vision Correction.
For Accommodative Lenses Deepak Chitkara, M.B., ChB. D.O.
USAMA MOURIS BEBAWY, MB MBCh CLINICAL FELLOW, MCMASTER UNIV No Financial Disclosure GEORGE H.H. BEIKO, B.M.,B.Ch.,FRCSC ST. CATHARINES, CANADA ASSIST PROF,
Change in Patient-Reported Outcomes and Visual Acuity After Bilateral Implantation of Apodized Diffractive +3.0 IOLs Stephen Lane, MD Consultant, Alcon.
Neeti Parikh, MD Fuxiang Zhang, MD Department of Ophthalmology Henry Ford Hospital A Comparison Of Patient Satisfaction With Modified Monovision Versus.
Evaluation of Safety and Effectiveness of Multizone Laser Vision Correction in Presbyopic Patients ASCRS 2010 Paul Van Saarloos PhD – CustomVis, employee.
Topical Cyclosporine for Postoperative use in PRK and LASIK: Preliminary Results LCDR David D. Hessert, M.D. Ophthalmology Chief Resident Naval Medical.
SK Kwok, MD Hong Kong Laser Eye Centre, Hong Kong The author has no financial interest in the subject matter of this e-poster ASCRS 2011 San Diego, US.
March 2011 Bascom Palmer Eye Institute University of Miami Elaine Wu, M.D. Ana Paula Canto, M.D. William Culbertson, M.D. Sonia Yoo, M.D. Financial disclosure:
Kaori Morii, M.D. Shinji Miura, M.D, Ph.D. Dept. of Ophthalmology, Asagiri Hospital, Hyogo, JPN We have no financial interest. This retrospective study.
Results of Collagen Crosslinking followed by posterior chamber toric implantable collamer lens implantation in patients with Keratoconus & High Myopia.
M. Vokrojova MD, M. Vokrojova MD, D. Sivekova MD, L. Wagnerova MD D. Sivekova MD, L. Wagnerova MD Prof. P. Kuchynka MD, PhD Prof. P. Kuchynka MD, PhD The.
Myoung Joon Kim, MD / Sara Yoon, MD Tracy Purcell, PhD / David J Schanzlin, MD L aser In Situ Keratomileusis versus Photorefractive Keratectomy for the.
REFRACTIVE OUTCOMES WITH TORIC ICL IMPLANTS CHIEF AUTHOR: Dr. D.RAMAMURTHY CO – AUTHOR: Dr. R.CHITRA The authors have no financial interest in the subject.
Refractec ViewPoint™ CK System for the Treatment of Spherical Hyperopia Sheryl Berman, MD Medical Officer FDA/CDRH/ODE/DOED.
Monovision King Saud University College of Medicine
Ray T. Oyakawa, M.D., M.B.A. ASCRS Boston 2010 No financial interests Vector Analysis for Astigmatism Management in Cataract Surgery.
Evaluation of Efficacy and Safety of Intracorneal Ring Segment (Intacs SK) in Keratoconus Abdulrahman Al-Muammar, MD, FRCSC I have no financial interest.
Faik Orucov*, MD, Sinan Goker*,MD, Abraham Solomon**, MD, Joseph Frucht-Pery**, MD *Refractive Surgery Department, ISTANBUL SURGERY HOSPITAL Istanbul,
Controversies about binocular function and patient satisfaction after induced conventional monovision in case of bilateral intraocular lens implantation.
10 year follow up of LASIK surgery for low to high levels of myopia Qasim Qasem FRCS, Caitriona Kirwan MRCOpth, Michael O’Keefe FRCS. Institutional Affiliations:
DR. TEJAS D. SHAH AMDAVAD EYE LASER HOSPITALS PVT LTD GOOD BYE GLASSES LASER CENTRE AHMEDABAD, INDIA NO FINANCIAL INTEREST
S. Lee/M.Kim 2010 M. Kim 1, H. Lee 1, S. Lee 1,, S.D. Lee 1 1 ASA-Vision Clinics Seoul Comparative Analysis Preliminary Results of.
EVEREST II Study Design Multicenter Randomized in a 2:1 ratio to either percutaneous or conventional surgery for the repair or replacement of the mitral.
Jay Fiore MD, Eric Donnenfeld MD, Hank Perry MD, Dana Morschauser OD
Laser Thermal Keratoplasty in Patients with Hyperopia of Presbyopic Age Alexander V. Doga, MD, PhD, DSc, Alexander A. Shpak, MD, PhD, DSc, Irina A. Mushkova,
Presbia: a new solution for presbyopia correction Dr M. Fantozzi (1), Dr I. Lenzetti (2), Dr A. Canovetti (1) (1) Casa di cura “Barbantini”, Lucca, Italy;
Theme 7: Optical neutralization of the ametropias Principle and value of neutralization. Influence of the vertex distance. Neutralization of the presbyopic.
Omni-Focal Treatment for Correction of Presbyopia in Hyperopes: 1 Year Results Efekan Coskunseven, Baha Toygar, Serife Atun, Haluk Talu, Ebru Arslan Dunya.
9-Month Results after Implantation of a new accommodative IOL that works with one focus Mark Tomalla M.D.* Clinic for Refractive and Ophthalmic Surgery,
Poster produced by Faculty & Curriculum Support (FACS), Georgetown University School of Medicine LASIK Combined with Corneal Cross-linking in Eyes with.
Corneal Biomechanical Changes Following Surface Keratorefractive Surgery Teeravee Hongyok, MD, Christopher J. Rapuano, MD, Ajoy Virdi, MBBS, Elisabeth.
Corneal CXL in Pediatric Patients with Progressive Keratoconus Stephanie Wise, Christian Diaz, Karolien Termote, Paul J. Dubord, Martin McCarthy, Sonia.
Postoperative Uncorrected Visual Acuity (UCVA) versus Preoperative Best Corrected Visual Acuity (BCVA) with the WaveLight Refractive Suite (Excimer EX500.
CustomVue vs Conventional LASIK: one year study
and High-Order Aberrations After Intrastromal Presbyopia Correction
University of Florence Oto-Neuro-Ophthalmological Department
Early Experience with Descemet’s Stripping Automated Endothelial Keratoplasty Combined with Phacoemulsification: Clinical and Refractive Outcome University.
Hallett H. Mathews, M.D. Richmond, Virginia
The authors have no financial interest to disclosure
SurgiVision® DataLink Study Group
V isual Outcomes and Complications of Mini-Enhancements after Refractive Surgery Lichtinger A, MD; Purcell TL, Ph.D; Bernabe-Ko J, MD; Schanzlin DJ, MD.
University of California, San Diego Shiley Eye Center
Presentation transcript:

Conductive Keratoplasty for the Treatment of Presbyopic Emmetropes and Hyperopes to Improve Near Vision FDA Clinical Trial Protocol RCS-0110PRS 24 Month Data

CK Presbyopia FDA Clinical Trial Protocol RCS-011-PRS A Prospective Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ViewPoint CK System for the improvement in near vision in Presbyopic Emmetropes and Hyperopes utilizing the Conductive Keratoplasty (CK) Procedure

CK Presbyopia FDA Clinical Trial Protocol RCS-011-PRS 188 eyes of 150 subjects 61% female 39% male Mean age: 52.9 years old Age range: (43.7, 70.8) years old Mean Target: Target range: (-1.00, -2.25)

CK Presbyopia FDA Clinical Trial Protocol RCS-011-PRS 24 Month Data Treatment range (+1.00 to +2.25D) –16 and 24 spot patterns –Conventional Pressure Myopic target (-1.00 to -2.00D) –non-dominant eye for monovision

CK Presbyopia FDA Clinical Trial Protocol RCS-011-PRS 24 Month Data Safety –Preservation of BSCVA No eyes (0%) report loss of > 2 lines of BSCVA at 24 months –Induced Cylinder 97% have no clinically significant IC at 24 months –Adverse Events No Device or Procedure related Ocular AEs reported at 24M –Complications No Complications reported at 24M

CK Presbyopia FDA Clinical Trial Protocol RCS-011-PRS 24 Month Data Efficacy (Emmetropic Presbyopes) –Accuracy to 24 Months D = 53% D = 91% –UCVA-N 75% of eyes treated are J3 or better at 24 months 51% of eyes treated are J2 or better at 24 months

CK Presbyopia FDA Clinical Trial Protocol RCS-011-PRS 24 Month Data Subjective Response –Quality of Vision: 87% (Moderate, Marked or Extreme Improvement at 24 months) –Patient Satisfaction 79% (Satisfied or Very Satisfied at 24 months) –Quality of Depth Perception Pre-op: 94% (Good, Very Good or Excellent) 24 months: 90% (G, VG, E)

CK Presbyopia FDA Clinical Trial Protocol RCS-011-PRS 24 Month Data Key issue is STABILITY –MRSE over time –Average Keratometry over time –In the Eye treated for Near: UCVA-Near over time UCVA-Distance over time –Binocular UCVA-Distance and Near –Patient’s Subjective Perception over time

MRSE over time

Average K over time

Monocular UCVA-D and N

Binocular UCVA-D and N

What can you see without glasses?